Sensitivity and specificity of metabolic syndrome criteria for insulin resistance diagnosis in Spanish population;Sensibilidad y especificidad de los criterios del síndrome metabólico para el diagnóstico de insulinorresistencia en la población española

Medicina Clinica

Volumn 128, Issue 5, 2007, Pages 168-171

  Meriño Ibarra, Erardo ^a   Cenarro, Ana ^a   Martín, Paula ^a   García Otín, Ángel Luis ^a   Goicoechea, Jesús ^a   Guallar, Ana ^a   Calvo, Luisa ^a   Civeira, Fernando ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Diagnosis; HOMA; Insulin resistance; Metabolic syndrome; Waist circumference

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; SENSITIVITY AND SPECIFICITY; SPAIN; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 33847701257     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13098390     Document Type: Article

References (20)

1. Grundy SM, Cleeman Jl, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-52.
2. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-8.
3. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-28.
4. Himsworth HP. The mechanism of diabetes mellitus, I. Lancet. 1939;2:1-6.
5. Reaven G. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
7. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
8. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442-3.
9. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:237-52.
10. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289-304.
11. Grundy SM. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol. 2005;25:2243-4.
12. Alberti KGMM, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome -a new worldwide definition. Lancet. 2005;366:1059-62.
13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72.
14. Merino-Ibarra E, Artieda M, Cenarro A, Goicoechea J, Calvo L, Guallar A, et al. Ultrasonography for the evaluation of visceral fat and the metabolic syndrome. Metabolism. 2005;54:1230-35.
15. Bairaktari E, Hatzidimou K, Tzallas C, Vini M, Katsaraki A, Tselepis A, et al. Estimation of LDL Cholesterol Based on the Friedewald Formula and on Apo B Levels. Clin Biochem. 2000;33:549-55.
16. McAuley KA, Williams SH, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24:460-4.
17. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R. Cuantificación de insulinorresistencia con los valores de insulina basal e indice HOMA en una población no diabética. Med Clin (Barc). 2001;117:530-3.
18. American Diabetes Association. Consensus Development Conference on Insulin Resistance. Diabetes Care. 1998;21:310-14.
19. Skrha J, Haas T, Sindelka G, Prazny M, Widimsky J, Cibula D, et al. Comparison of the Insulin Action Parameters from Hyperinsulinemic Clamps with Homeostasis Model Assessment and QUICKI Indexes in Subjects with Different Endocrine Disorders. J Clin Endocrinol Metab. 2004;89:135-41.
20. Liao Y, Kwon S, Shaughnessy S, Wallace P, Hutto A, Jenkins AJ, et al. Critical Evaluation of Adult Treatment Panel III Criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004;27:978-83.